Antimicrobial resistance is a serious and challenging global unmet medical need. FCAR will leverage collaborations around the world from both the public and the private sectors to create global solutions to this pandemic. The programs will be designed to advance drug therapies as efficiently and rapidly as possible by taking full advantage of the strengths of the partners.